nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—ADORA1—nerve—acquired immunodeficiency syndrome	0.0141	0.0831	CbGeAlD
Gabapentin—BCAT1—retina—acquired immunodeficiency syndrome	0.00917	0.0541	CbGeAlD
Gabapentin—CACNA1B—spinal cord—acquired immunodeficiency syndrome	0.00752	0.0443	CbGeAlD
Gabapentin—CACNA1B—lung—acquired immunodeficiency syndrome	0.00684	0.0403	CbGeAlD
Gabapentin—CACNA1B—nervous system—acquired immunodeficiency syndrome	0.00633	0.0373	CbGeAlD
Gabapentin—CACNA1B—central nervous system—acquired immunodeficiency syndrome	0.0061	0.036	CbGeAlD
Gabapentin—BCAT1—spinal cord—acquired immunodeficiency syndrome	0.00591	0.0349	CbGeAlD
Gabapentin—BCAT1—vagina—acquired immunodeficiency syndrome	0.00569	0.0335	CbGeAlD
Gabapentin—CACNA2D2—spinal cord—acquired immunodeficiency syndrome	0.00542	0.032	CbGeAlD
Gabapentin—BCAT1—lung—acquired immunodeficiency syndrome	0.00538	0.0317	CbGeAlD
Gabapentin—CACNA2D2—vagina—acquired immunodeficiency syndrome	0.00521	0.0307	CbGeAlD
Gabapentin—BCAT1—nervous system—acquired immunodeficiency syndrome	0.00498	0.0294	CbGeAlD
Gabapentin—CACNA2D2—lung—acquired immunodeficiency syndrome	0.00493	0.0291	CbGeAlD
Gabapentin—CACNA1B—brain—acquired immunodeficiency syndrome	0.00484	0.0285	CbGeAlD
Gabapentin—BCAT1—central nervous system—acquired immunodeficiency syndrome	0.0048	0.0283	CbGeAlD
Gabapentin—CACNA1B—lymph node—acquired immunodeficiency syndrome	0.00468	0.0276	CbGeAlD
Gabapentin—CACNA2D2—nervous system—acquired immunodeficiency syndrome	0.00457	0.0269	CbGeAlD
Gabapentin—CACNA2D2—central nervous system—acquired immunodeficiency syndrome	0.0044	0.0259	CbGeAlD
Gabapentin—CACNA2D1—bone marrow—acquired immunodeficiency syndrome	0.00392	0.0231	CbGeAlD
Gabapentin—BCAT1—brain—acquired immunodeficiency syndrome	0.00381	0.0224	CbGeAlD
Gabapentin—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.00376	0.0222	CbGeAlD
Gabapentin—CACNA2D1—vagina—acquired immunodeficiency syndrome	0.00375	0.0221	CbGeAlD
Gabapentin—BCAT1—lymph node—acquired immunodeficiency syndrome	0.00368	0.0217	CbGeAlD
Gabapentin—ADORA1—vagina—acquired immunodeficiency syndrome	0.00362	0.0213	CbGeAlD
Gabapentin—CACNA2D1—lung—acquired immunodeficiency syndrome	0.00355	0.0209	CbGeAlD
Gabapentin—CACNA2D2—brain—acquired immunodeficiency syndrome	0.00349	0.0206	CbGeAlD
Gabapentin—ADORA1—lung—acquired immunodeficiency syndrome	0.00342	0.0202	CbGeAlD
Gabapentin—CACNA2D2—lymph node—acquired immunodeficiency syndrome	0.00337	0.0199	CbGeAlD
Gabapentin—CACNA2D1—nervous system—acquired immunodeficiency syndrome	0.00328	0.0194	CbGeAlD
Gabapentin—ADORA1—nervous system—acquired immunodeficiency syndrome	0.00317	0.0187	CbGeAlD
Gabapentin—CACNA2D1—central nervous system—acquired immunodeficiency syndrome	0.00316	0.0186	CbGeAlD
Gabapentin—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.00305	0.018	CbGeAlD
Gabapentin—CACNA2D1—brain—acquired immunodeficiency syndrome	0.00251	0.0148	CbGeAlD
Gabapentin—CACNA2D1—lymph node—acquired immunodeficiency syndrome	0.00243	0.0143	CbGeAlD
Gabapentin—ADORA1—brain—acquired immunodeficiency syndrome	0.00242	0.0143	CbGeAlD
Gabapentin—ADORA1—lymph node—acquired immunodeficiency syndrome	0.00234	0.0138	CbGeAlD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000247	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000246	CcSEcCtD
Gabapentin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000204	0.000246	CcSEcCtD
Gabapentin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000246	CcSEcCtD
Gabapentin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000246	CcSEcCtD
Gabapentin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000246	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000246	CcSEcCtD
Gabapentin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000245	CcSEcCtD
Gabapentin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000245	CcSEcCtD
Gabapentin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000203	0.000244	CcSEcCtD
Gabapentin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000203	0.000244	CcSEcCtD
Gabapentin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000244	CcSEcCtD
Gabapentin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000244	CcSEcCtD
Gabapentin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000244	CcSEcCtD
Gabapentin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000243	CcSEcCtD
Gabapentin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000243	CcSEcCtD
Gabapentin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.000242	CcSEcCtD
Gabapentin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.000242	CcSEcCtD
Gabapentin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.000242	CcSEcCtD
Gabapentin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000242	CcSEcCtD
Gabapentin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000242	CcSEcCtD
Gabapentin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.0002	0.000241	CcSEcCtD
Gabapentin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0002	0.000241	CcSEcCtD
Gabapentin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000241	CcSEcCtD
Gabapentin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000241	CcSEcCtD
Gabapentin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000241	CcSEcCtD
Gabapentin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00024	CcSEcCtD
Gabapentin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.00024	CcSEcCtD
Gabapentin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00024	CcSEcCtD
Gabapentin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00024	CcSEcCtD
Gabapentin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000239	CcSEcCtD
Gabapentin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000239	CcSEcCtD
Gabapentin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000239	CcSEcCtD
Gabapentin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000239	CcSEcCtD
Gabapentin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000238	CcSEcCtD
Gabapentin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000198	0.000238	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000238	CcSEcCtD
Gabapentin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000237	CcSEcCtD
Gabapentin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000237	CcSEcCtD
Gabapentin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000236	CcSEcCtD
Gabapentin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000235	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000235	CcSEcCtD
Gabapentin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000235	CcSEcCtD
Gabapentin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000234	CcSEcCtD
Gabapentin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000234	CcSEcCtD
Gabapentin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000234	CcSEcCtD
Gabapentin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000194	0.000234	CcSEcCtD
Gabapentin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000234	CcSEcCtD
Gabapentin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000233	CcSEcCtD
Gabapentin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000194	0.000233	CcSEcCtD
Gabapentin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000194	0.000233	CcSEcCtD
Gabapentin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000233	CcSEcCtD
Gabapentin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000233	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000233	CcSEcCtD
Gabapentin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000232	CcSEcCtD
Gabapentin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000193	0.000232	CcSEcCtD
Gabapentin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000232	CcSEcCtD
Gabapentin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000232	CcSEcCtD
Gabapentin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000232	CcSEcCtD
Gabapentin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000231	CcSEcCtD
Gabapentin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000231	CcSEcCtD
Gabapentin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.00023	CcSEcCtD
Gabapentin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.00023	CcSEcCtD
Gabapentin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000191	0.00023	CcSEcCtD
Gabapentin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000191	0.00023	CcSEcCtD
Gabapentin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.00023	CcSEcCtD
Gabapentin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000191	0.00023	CcSEcCtD
Gabapentin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000229	CcSEcCtD
Gabapentin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000229	CcSEcCtD
Gabapentin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00019	0.000229	CcSEcCtD
Gabapentin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000228	CcSEcCtD
Gabapentin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000228	CcSEcCtD
Gabapentin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000228	CcSEcCtD
Gabapentin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000228	CcSEcCtD
Gabapentin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000228	CcSEcCtD
Gabapentin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000227	CcSEcCtD
Gabapentin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000227	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000227	CcSEcCtD
Gabapentin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000227	CcSEcCtD
Gabapentin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000226	CcSEcCtD
Gabapentin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000226	CcSEcCtD
Gabapentin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000225	CcSEcCtD
Gabapentin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000225	CcSEcCtD
Gabapentin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000225	CcSEcCtD
Gabapentin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.000225	CcSEcCtD
Gabapentin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000225	CcSEcCtD
Gabapentin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000186	0.000224	CcSEcCtD
Gabapentin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000224	CcSEcCtD
Gabapentin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000223	CcSEcCtD
Gabapentin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000185	0.000223	CcSEcCtD
Gabapentin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000185	0.000223	CcSEcCtD
Gabapentin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000223	CcSEcCtD
Gabapentin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000223	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000223	CcSEcCtD
Gabapentin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000222	CcSEcCtD
Gabapentin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000222	CcSEcCtD
Gabapentin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000222	CcSEcCtD
Gabapentin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000222	CcSEcCtD
Gabapentin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000222	CcSEcCtD
Gabapentin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000184	0.000222	CcSEcCtD
Gabapentin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000184	0.000221	CcSEcCtD
Gabapentin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000184	0.000221	CcSEcCtD
Gabapentin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000221	CcSEcCtD
Gabapentin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.00022	CcSEcCtD
Gabapentin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.00022	CcSEcCtD
Gabapentin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.00022	CcSEcCtD
Gabapentin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00022	CcSEcCtD
Gabapentin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000182	0.000219	CcSEcCtD
Gabapentin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000182	0.000219	CcSEcCtD
Gabapentin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000219	CcSEcCtD
Gabapentin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000219	CcSEcCtD
Gabapentin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000219	CcSEcCtD
Gabapentin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000181	0.000218	CcSEcCtD
Gabapentin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000218	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000217	CcSEcCtD
Gabapentin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.000217	CcSEcCtD
Gabapentin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00018	0.000217	CcSEcCtD
Gabapentin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000216	CcSEcCtD
Gabapentin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000215	CcSEcCtD
Gabapentin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000215	CcSEcCtD
Gabapentin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000214	CcSEcCtD
Gabapentin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000214	CcSEcCtD
Gabapentin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000214	CcSEcCtD
Gabapentin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000214	CcSEcCtD
Gabapentin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000213	CcSEcCtD
Gabapentin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000213	CcSEcCtD
Gabapentin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000213	CcSEcCtD
Gabapentin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000213	CcSEcCtD
Gabapentin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000212	CcSEcCtD
Gabapentin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000212	CcSEcCtD
Gabapentin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000212	CcSEcCtD
Gabapentin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000211	CcSEcCtD
Gabapentin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000175	0.00021	CcSEcCtD
Gabapentin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000175	0.00021	CcSEcCtD
Gabapentin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00021	CcSEcCtD
Gabapentin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.00021	CcSEcCtD
Gabapentin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000174	0.00021	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000209	CcSEcCtD
Gabapentin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000209	CcSEcCtD
Gabapentin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000208	CcSEcCtD
Gabapentin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000207	CcSEcCtD
Gabapentin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000206	CcSEcCtD
Gabapentin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000206	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000206	CcSEcCtD
Gabapentin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000206	CcSEcCtD
Gabapentin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000205	CcSEcCtD
Gabapentin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000205	CcSEcCtD
Gabapentin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000205	CcSEcCtD
Gabapentin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000205	CcSEcCtD
Gabapentin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000204	CcSEcCtD
Gabapentin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000204	CcSEcCtD
Gabapentin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000204	CcSEcCtD
Gabapentin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000204	CcSEcCtD
Gabapentin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000204	CcSEcCtD
Gabapentin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000203	CcSEcCtD
Gabapentin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000202	CcSEcCtD
Gabapentin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000202	CcSEcCtD
Gabapentin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000199	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000199	CcSEcCtD
Gabapentin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000199	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000198	CcSEcCtD
Gabapentin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000198	CcSEcCtD
Gabapentin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000198	CcSEcCtD
Gabapentin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000197	CcSEcCtD
Gabapentin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000196	CcSEcCtD
Gabapentin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000196	CcSEcCtD
Gabapentin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000196	CcSEcCtD
Gabapentin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000195	CcSEcCtD
Gabapentin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000195	CcSEcCtD
Gabapentin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.000195	CcSEcCtD
Gabapentin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000195	CcSEcCtD
Gabapentin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000195	CcSEcCtD
Gabapentin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000193	CcSEcCtD
Gabapentin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000193	CcSEcCtD
Gabapentin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000193	CcSEcCtD
Gabapentin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000193	CcSEcCtD
Gabapentin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000192	CcSEcCtD
Gabapentin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000191	CcSEcCtD
Gabapentin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.00019	CcSEcCtD
Gabapentin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00019	CcSEcCtD
Gabapentin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000189	CcSEcCtD
Gabapentin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000189	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000189	CcSEcCtD
Gabapentin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000189	CcSEcCtD
Gabapentin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000189	CcSEcCtD
Gabapentin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000188	CcSEcCtD
Gabapentin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000188	CcSEcCtD
Gabapentin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000188	CcSEcCtD
Gabapentin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000187	CcSEcCtD
Gabapentin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000187	CcSEcCtD
Gabapentin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000185	CcSEcCtD
Gabapentin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000184	CcSEcCtD
Gabapentin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000182	CcSEcCtD
Gabapentin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000182	CcSEcCtD
Gabapentin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000182	CcSEcCtD
Gabapentin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000181	CcSEcCtD
Gabapentin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000181	CcSEcCtD
Gabapentin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000181	CcSEcCtD
Gabapentin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00018	CcSEcCtD
Gabapentin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000149	0.00018	CcSEcCtD
Gabapentin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000149	0.00018	CcSEcCtD
Gabapentin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000179	CcSEcCtD
Gabapentin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000179	CcSEcCtD
Gabapentin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000178	CcSEcCtD
Gabapentin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000176	CcSEcCtD
Gabapentin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000176	CcSEcCtD
Gabapentin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000174	CcSEcCtD
Gabapentin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000173	CcSEcCtD
Gabapentin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000173	CcSEcCtD
Gabapentin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000171	CcSEcCtD
Gabapentin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000171	CcSEcCtD
Gabapentin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000171	CcSEcCtD
Gabapentin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.00017	CcSEcCtD
Gabapentin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.00017	CcSEcCtD
Gabapentin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000169	CcSEcCtD
Gabapentin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000169	CcSEcCtD
Gabapentin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000169	CcSEcCtD
Gabapentin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000169	CcSEcCtD
Gabapentin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000165	CcSEcCtD
Gabapentin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000164	CcSEcCtD
Gabapentin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000163	CcSEcCtD
Gabapentin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000163	CcSEcCtD
Gabapentin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000162	CcSEcCtD
Gabapentin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000162	CcSEcCtD
Gabapentin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000162	CcSEcCtD
Gabapentin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000161	CcSEcCtD
Gabapentin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.00016	CcSEcCtD
Gabapentin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000158	CcSEcCtD
Gabapentin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000157	CcSEcCtD
Gabapentin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000157	CcSEcCtD
Gabapentin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000155	CcSEcCtD
Gabapentin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000153	CcSEcCtD
Gabapentin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000152	CcSEcCtD
Gabapentin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000152	CcSEcCtD
Gabapentin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.00015	CcSEcCtD
Gabapentin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.00015	CcSEcCtD
Gabapentin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.00015	CcSEcCtD
Gabapentin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000149	CcSEcCtD
Gabapentin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000146	CcSEcCtD
Gabapentin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000145	CcSEcCtD
Gabapentin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000145	CcSEcCtD
Gabapentin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000145	CcSEcCtD
Gabapentin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000144	CcSEcCtD
Gabapentin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000142	CcSEcCtD
Gabapentin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000139	CcSEcCtD
Gabapentin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000138	CcSEcCtD
Gabapentin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000138	CcSEcCtD
Gabapentin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000137	CcSEcCtD
Gabapentin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000136	CcSEcCtD
Gabapentin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00013	CcSEcCtD
